Milan R. Henzl

No ORCID on file · 20 papers in corpus · active 1973-2009

Study types

  • article 16
  • book-chapter 2
  • review 2

Condition tags

  • endometriosis 12
  • dysmenorrhea 3
  • chronic_pelvic_pain 2
article 2009
·doi:10.1159/000271636
article 1998
The Journal of reproductive medicine

OBJECTIVE: To project the efficacy and economic consequence of short-term intranasal gonadotropin-releasing hormone agonist (GnRH-a) for diagnosis of and therapy for endometriosis. STUDY DESIGN: Multicenter, placebo-controlled clinical tria…

article 1998
The Journal of reproductive medicine

OBJECTIVE: To draw attention to the structural features of adhesions associated with pelvic endometriosis since they are less well studied than endometriosis proper. STUDY DESIGN: Sixty-two samples of periovarian adhesions were laparoscopic…

article 1997
The Journal of reproductive medicine

OBJECTIVE: To compare intranasal nafarelin and intramuscular leuprolide acetate (LA) depot in the management of endometriosis. STUDY DESIGN: A multicenter, prospective, randomized, double-placebo, double-blind study was conducted on subject…

article 1997
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(97)70084-x
article 1995
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(95)90348-8
review 1992
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(92)91709-j
article 1990
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(90)90432-7
article 1988
The New England journal of medicine ·doi:10.1056/nejm198802253180805

Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces hypoestrogenemia. To determine the efficacy of such hormonal manipulation in the treatment of endometriosis, we randomly as…

review 1988
Clinical obstetrics and gynecology ·doi:10.1097/00003081-198812000-00010
book-chapter 1987
·doi:10.1159/000414897
book-chapter 1987
·doi:10.1007/978-94-009-3229-6_22
article 1985
Fertility and Sterility ·doi:10.1016/s0015-0282(16)48970-3
article 1981
·doi:10.1016/0002-9378(81)90238-6
article 1979
·doi:10.1016/0002-9378(79)90430-7
article 1979
·doi:10.3109/00016347909157802

Abstract. “In vitro” experimentation has shown that naproxen inhibits prostaglandin synthetase generated by uterine microsomes of pregnant rats. In another in vitro system, naproxen inhibited electrically induced contractions of an isolated…

article 1978
·doi:10.1016/0090-6980(78)90138-7
article 1977
·doi:10.1016/0090-6980(77)90056-9
article 1973
·doi:10.1016/0002-9378(73)90094-x
article 1973
·doi:10.1210/jcem-36-4-784

An iv infusion of prostaglandin E2 (PGE2) was given for 8 hr on 2-3 consecutive days to 7 normally cycling women during various periods of the luteal phase, and to 1 woman whose luteal phase was prolonged by hCG administration. Three women …